Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by/4.0